1. McVary KT, Rogers T, Roehrborn CG. Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. Urology. 2019;126:171–17
2.McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2021:206(3):715–724.*
3. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rezūm water vapor thermal therapy for treatment ofmoderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021 Apr 19. Online ahead of print.
4. Rezum II Trial – BSC data on file.
5. McVary KT, Roehrborn CG. Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm™ System Study: Convective Radiofrequency Thermal Therapy for Treatmentof Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Urology. Elsevier Inc.; 2018;111: 1–9. doi:10.1016/j.urology.2017.10.023.
6. McVary KT, Rogers T, Roehrborn CG. Rezūm™ Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year ResultsFrom Randomized Controlled Study. Urology. Elsevier Inc.; 2019;126: 171–179. doi:10.1016/j.urology.2018.12.041.
7. McVary KT, Roehrborn C. Five year results of the prospective, arndomized, controlled trial of water thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.J Urol. 2020;203: e1021
8. Westwood J, Geraghty R, Jones P, et al. Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. Ther Adv Urol. 10(11):327–333.
9. Ulchaker JC, Martinson MS. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Clinicoecon Outcomes Res. 2017;10:29–43.
10. NICE Guidance on Rezum https://www.nice.org.uk/guidance/mtg49/chapter/1-Recommendations
11. Rob S Blissett, Deirdre B Blissett, Martina Oselin, et al. Transurethral water vapor therapy for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cost-minimization and budget impact analysis from an Italian healthcare perspective, Minerva Urol Nephrol. 2022 Dec 23.
12. Alberto De la Cuadra-Grande, Jorge Rioja-Zuazu,Mario Domínguez-Esteban, et al., Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system, Expert Rev Pharmacoecon Outcomes Res. 2023 Mar 20;1-12. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.